The new European Medicines Agency guideline on antidepressants: a guide for researchers and drug developers

According to the World Health Organization (WHO), depressive disorders are currently considered as one of the most disabling medical conditions in the world with one of the highest disability-adjusted life years [1] and this situation has apparently been further worsened during the COVID-19 pandemic...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Florence Butlen-Ducuing, Marion Haberkamp, Georgios Aislaitner, Ewa Bałkowiec-Iskra, Taina Mattila, Marika Doucet, Marta Kollb-Sielecka, Pavel Balabanov, Ann-Kristin Leuchs, André Elferink
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Cambridge University Press 2024-01-01
סדרה:	European Psychiatry
נושאים:	Depression medicines Clinical trial innovation EMA
גישה מקוונת:	https://www.cambridge.org/core/product/identifier/S0924933823024793/type/journal_article
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!